Embarr Downs, Inc. (OTC: EMBR) today announced the acquisition of NexGen2780, which will serve as the Company’s dedicated acquisition subsidiary for its branded spirits division. The subsidiary is intended to house and consolidate Embarr’s premium spirits holdings under a single, focused structure.
The move formalizes Embarr’s strategy of building a branded spirits platform through disciplined acquisition and consolidation. By organizing its spirits assets under NexGen2780, the Company aims to streamline operations, support future brand acquisitions, and create a clear structure for growth within the category.
Mark A. Jones, President and Chief Executive Officer of Embarr Downs, also serves as Managing Partner of NexGen2780, providing unified leadership across the Company and its spirits subsidiary.
“NexGen2780 gives us a purpose-built home for our spirits portfolio,” said Jones. “As we continue building in the branded spirits space, having a dedicated subsidiary to consolidate and grow these assets lets us move with focus and discipline. This is another building block in the foundation we’re laying at Embarr.”
The Company intends to provide additional details regarding the subsidiary’s holdings and its role within Embarr’s broader acquisition strategy in future disclosures.
About Embarr Downs, Inc.
Embarr Downs, Inc. (OTC: EMBR) is a Nevada-incorporated holding company focused on acquiring undervalued, revenue-generating assets in high-growth, fragmented sectors — including regenerative health and branded spirits — and building long-term value through operational discipline and strategic acquisition.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements reflect the Company’s current expectations and are subject to risks and uncertainties that could cause actual results to differ materially. Words such as “intends,” “aims,” “plans,” and similar expressions identify forward-looking statements. There is no assurance the Company will achieve the outcomes described. The Company undertakes no obligation to update these statements except as required by law. Investors should review the Company’s disclosures on OTC Markets.